At Iconthin Biotech, we pride ourselves on our commitment to innovation, quality, and sustainability. Our advanced microfluidic technology, industry certifications, accreditations, and published research demonstrate our dedication to providing the best possible algae-based products and solutions.
Our microfluidic platform enables us to conduct in-situ observation of single microalgae cells for strain selection, growth optimization, cell-wall disruption, bioactive extraction, and finished product encapsulation. This state-of-the-art technology enhances our fundamental understanding of microalgae, leading to the development of cost-effective ingredients from microalgal biomass and accelerating the applications of these ingredients.
Iconthin Biotech adheres to the highest quality and safety standards, and our certifications and accreditations reflect this commitment. Our facilities are certified for Good Manufacturing Practices (GMP), ensuring that our products are consistently produced and controlled according to the highest quality standards. We are also certified by the International Organization for Standardization (ISO), demonstrating our dedication to quality management systems and continuous improvement.
Iconthin Biotech has contributed to the advancement of microalgae research through the publication of scientific papers. Our research, using the microfluidic platform, has focused on the production of astaxanthin from Haematococcus pluvialis microalgae, covering topics such as microfluidic platform development, cell-wall disruption, and supercritical CO2 extraction.
Some of our key publications include:
Our team has developed a hydrothermal method of extracting astaxanthin from wet biomass using a high temperature and high-pressure microfluidic platform. We were able to trap Haematococcus pluvialis cysts within the device and observe the cell wall disruption and astaxanthin extraction process in real-time.
We found that hydrothermal disruption at a temperature of 200°C was highly effective, resulting in nearly complete astaxanthin extraction from wet biomass. This represents a significant improvement over traditional extraction methods.
In this study, we demonstrated the effectiveness of using low-pressure supercritical CO2 to extract astaxanthin from disrupted Haematococcus pluvialis. We were able to achieve 92% recovery using this method at 55°C and 8 MPa applied over 15 hours. In comparison, using ethanol as the solvent resulted in a much faster extraction process, taking only 30 seconds at the same temperature and pressure.
This represents the fastest complete astaxanthin extraction at such low pressures, a significant improvement over traditional methods.
Our advanced technology, industry recognitions, and published research underline our dedication to providing the highest-quality, innovative, and sustainable algae-based products and solutions for our customers.